Pariya L Fazeli1, Michael Crowe1, Lesley A Ross1, Virginia Wadley2, Karlene Ball1, David E Vance3. 1. Edward R. Roybal Center for Translational Research in Aging and Mobility; University of Alabama at Birmingham; Birmingham, AL, USA ; Department of Psychology; University of Alabama at Birmingham; Birmingham, AL, USA. 2. Edward R. Roybal Center for Translational Research in Aging and Mobility; University of Alabama at Birmingham; Birmingham, AL, USA ; School of Medicine; University of Alabama at Birmingham; Birmingham, AL, USA. 3. Edward R. Roybal Center for Translational Research in Aging and Mobility; University of Alabama at Birmingham; Birmingham, AL, USA ; School of Nursing; University of Alabama at Birmingham; Birmingham, AL, USA.
Abstract
OBJECTIVE: This cross-sectional study examined cognitive subtypes and influential factors in HIV-positive (HIV+) adults. METHOD: Two-step cluster analysis was conducted on a neurocognitive test battery in a sample (N = 78) of adults and older adults with HIV (Mage = 46.1). Next, cognitive, functional, and mental and physical health differences were compared between the HIV+ clusters and an HIV- reference group (N = 84; Mage = 47.9). RESULTS: A two-cluster solution emerged, with a lower performing cluster exhibiting poorer performance across all domains except psychomotor speed, and a "normal" cluster displaying similar performance as the HIV- group. The most influential factors to classification in the lower performing cluster were older age and presence of stroke and hypertension. There were trends for longer duration of HIV-infection, higher unemployment rates, and greater prevalence of Hepatitis C co-infection in the lower performing cluster. CONCLUSIONS: These findings suggest that there are not unique cognitive subtypes in HIV, but rather a subset of individuals who exhibit globally normal performance and those with below average performance. Older age and the related cardiovascular comorbidities of both aging and HIV medications may be key influential factors to variability in neurocognitive functioning in this population and thus should be considered in future studies. Implications for research and practice are provided.
OBJECTIVE: This cross-sectional study examined cognitive subtypes and influential factors in HIV-positive (HIV+) adults. METHOD: Two-step cluster analysis was conducted on a neurocognitive test battery in a sample (N = 78) of adults and older adults with HIV (Mage = 46.1). Next, cognitive, functional, and mental and physical health differences were compared between the HIV+ clusters and an HIV- reference group (N = 84; Mage = 47.9). RESULTS: A two-cluster solution emerged, with a lower performing cluster exhibiting poorer performance across all domains except psychomotor speed, and a "normal" cluster displaying similar performance as the HIV- group. The most influential factors to classification in the lower performing cluster were older age and presence of stroke and hypertension. There were trends for longer duration of HIV-infection, higher unemployment rates, and greater prevalence of Hepatitis C co-infection in the lower performing cluster. CONCLUSIONS: These findings suggest that there are not unique cognitive subtypes in HIV, but rather a subset of individuals who exhibit globally normal performance and those with below average performance. Older age and the related cardiovascular comorbidities of both aging and HIV medications may be key influential factors to variability in neurocognitive functioning in this population and thus should be considered in future studies. Implications for research and practice are provided.
Authors: Karlene Ball; Daniel B Berch; Karin F Helmers; Jared B Jobe; Mary D Leveck; Michael Marsiske; John N Morris; George W Rebok; David M Smith; Sharon L Tennstedt; Frederick W Unverzagt; Sherry L Willis Journal: JAMA Date: 2002-11-13 Impact factor: 56.272
Authors: Hernando Knobel; Jordi Alonso; José L Casado; Julio Collazos; Juan González; Isabel Ruiz; José M Kindelan; Alexia Carmona; Javier Juega; Antonio Ocampo Journal: AIDS Date: 2002-03-08 Impact factor: 4.177
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: S Dawes; P Suarez; C Y Casey; M Cherner; T D Marcotte; S Letendre; I Grant; R K Heaton Journal: J Clin Exp Neuropsychol Date: 2008-03-04 Impact factor: 2.475
Authors: David E Vance; Pariya L Fazeli; Lesley A Ross; Virginia G Wadley; Karlene K Ball Journal: J Assoc Nurses AIDS Care Date: 2012-05-11 Impact factor: 1.354
Authors: Elizabeth C Pasipanodya; Jessica L Montoya; Laura M Campbell; Mariam A Hussain; Rowan Saloner; Emily M Paolillo; Dilip V Jeste; Scott L Letendre; J Allen McCutchan; Robert K Heaton; David J Moore Journal: Arch Clin Neuropsychol Date: 2021-02-12 Impact factor: 2.813
Authors: Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur Journal: Nat Rev Neurol Date: 2016-03-11 Impact factor: 42.937
Authors: Kristin R Krueger; Oluwatoyin Adeyemi; Sue Leurgans; Raj C Shah; Antonio D Jimenez; Lawrence Ouellet; Alan L Landay; David A Bennett; Lisa L Barnes Journal: AIDS Date: 2017-01-28 Impact factor: 4.177
Authors: David E Vance; Pariya L Fazeli; Joan E Dodson; Michelle Ackerman; Michele Talley; Susan J Appel Journal: J Neurosci Nurs Date: 2014-10 Impact factor: 1.230
Authors: Samantha A Molsberry; Yu Cheng; Lawrence Kingsley; Lisa Jacobson; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; James T Becker Journal: AIDS Date: 2018-07-31 Impact factor: 4.177